Sectors

MRKR
Marker Therapeutics, Inc.
1.36
2 x 0.96
2 x 1.75
bid
ask
-
0.01
0.73%
02:13 PM
timesize
Ytd-8.72%
1y46.24%
1.33
day range
1.41
0.83
52 week range
2.46
Open1.37Prev Close1.37Low1.33High1.41Mkt Cap22.68M
Vol54.23KAvg Vol64.89KEPS-0.38P/EN/AForward P/E-2.34
Beta1.50Short Ratio1.55Inst. Own22.44%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.31200-d Avg1.431yr Est19.00
Income Statement
Operating Expenses2.62M
Research and Development Expense1.48M
Selling, General and Administrative Expense1.14M
Operating Income-2.62M
Net Income-1.83M
Net Income Common Stock-1.83M
Net Income Common Stock (USD)-1.83M
Consolidated Income-1.83M
Earnings per Basic Share-0.09
Earnings per Basic Share (USD)-0.09
Earnings per Diluted Share-0.09
Earning Before Interest & Taxes (EBIT)-1.83M
Earning Before Interest & Taxes (USD)-1.83M
Weighted Average Shares19.31M
Weighted Average Shares Diluted19.31M
Balance Sheet
Cash and Equivalents11.92M
Cash and Equivalents (USD)11.92M
Trade and Non-Trade Receivables1.62M
Current Assets14.59M
Total Assets14.59M
Current Liabilities2.42M
Total Liabilities2.42M
Accumulated Retained Earnings (Deficit)-464.19M
Shareholders Equity12.17M
Shareholders Equity (USD)12.17M
Deferred Revenue591.31K
Trade and Non-Trade Payables1.83M
Cash Flow
Net Cash Flow / Change in Cash & Cash Equivalents-3.72M
Net Cash Flow from Operations-3.72M
Share Based Compensation195.74K